Guizhou Bailing Group Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 1.11% vs -30.50% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 106.90% vs -84.82% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "639.60",
          "val2": "632.60",
          "chgp": "1.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.20",
          "val2": "51.10",
          "chgp": "6.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.50",
          "val2": "20.90",
          "chgp": "-40.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.00",
          "val2": "2.90",
          "chgp": "106.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "84.70%",
          "val2": "31.70%",
          "chgp": "5.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -9.99% vs 20.69% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 108.92% vs -402.86% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,792.10",
          "val2": "4,213.10",
          "chgp": "-9.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "178.50",
          "val2": "-293.40",
          "chgp": "160.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "86.00",
          "val2": "93.10",
          "chgp": "-7.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "75.30",
          "val2": "6.70",
          "chgp": "1,023.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.80",
          "val2": "-412.50",
          "chgp": "108.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.10%",
          "val2": "-99.10%",
          "chgp": "11.32%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

639.60

632.60

1.11%

Operating Profit (PBDIT) excl Other Income

54.20

51.10

6.07%

Interest

12.50

20.90

-40.19%

Exceptional Items

0.00

0.00

Consolidate Net Profit

6.00

2.90

106.90%

Operating Profit Margin (Excl OI)

84.70%

31.70%

5.30%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 1.11% vs -30.50% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 106.90% vs -84.82% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

3,792.10

4,213.10

-9.99%

Operating Profit (PBDIT) excl Other Income

178.50

-293.40

160.84%

Interest

86.00

93.10

-7.63%

Exceptional Items

75.30

6.70

1,023.88%

Consolidate Net Profit

36.80

-412.50

108.92%

Operating Profit Margin (Excl OI)

14.10%

-99.10%

11.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -9.99% vs 20.69% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 108.92% vs -402.86% in Dec 2023

All Annual Results